Health Canada has approved Ocrevus for children 10 and older with relapsing-remitting MS, expanding treatment options for ...

A Phase 2 trial found that a lower dose of nasal foralumab significantly reduced brain inflammation markers in people with nonactive SPMS.

Trial data suggest a single infusion of the experimental CAR T-cell therapy zola-cel may stabilize disability in relapsing or ...

Early treatment with vidofludimus calcium may lead to less long-term disability in people with progressive forms of MS, data ...

Greater physical disability is associated with cognitive problems in people with multiple sclerosis, according to a review ...

New Phase 3 data show fenebrutinib reduced markers of chronic brain inflammation in both relapsing forms of MS and primary ...

Actor Christina Applegate's recent revelation of her MS misdiagnosis has sparked a discussion about the challenges of diagnosing the disease.

Physical activity programs for people with MS appear feasible and well received, but more research is needed on their use in ...

About four out of 10 people with MS in Thailand were found to be either at risk of malnutrition or already malnourished, a small study shows.

Vaccine fatigue' rose in MS after the COVID-19 pandemic; many patients lacked the protection they thought they had, a German ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Among people newly diagnosed with multiple sclerosis, B-cell-depleting treatments were associated ...